Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rang in Aktien #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Aktienkurs
$0.0003
Zuletzt synchronisiert: 2023-06-13
Marktkapitalisierung
$28.14K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Neuropathix, Inc. (NPTX)

Kategorie

Kursverlauf für Neuropathix, Inc. (NPTX)
Höchster Schlusskurs: $0.00 am 2023-06-01

Niedrigster Schlusskurs: $3.83 am 2019-12-01
Kursverlauf der Aktie von Neuropathix, Inc. von 2019 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -94.99%
2022 -87.62%
2021 -79.16%
2020 -93.93%
2019 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$745.48 9.02%
CH
$1.08K -6.68%
KR
$260.24 16.81%
BE